Skip to content
Recall Observatory FDA recall evidence

Drug product

2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Distributed by Hospira Inc., Lake Forest, IL 60045, NDC 0409-4903-11

D-0102-2024

October 02, 2023

Class I

Product summary

Firm
Pfizer Inc.
Event
Event 93124
Status
Terminated
Classification
Class I
Quantity
3,200 vials
Official record key
drug-enforcement:D-0102-2024

Official wording

Reason: Presence of Particulate Matter: identified as glass.

Code information: Lot#: GH6567, Exp. 7/1/2024

Distribution pattern: Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter